Stuart Rose is an active entrepreneur and investor emphasizing pharma/biotech and medical devices but with interests in any for-profit startup that solves problems, especially big problems. Fundamentally, Rose starts companies and invests in very early-stage companies with the potential to address the way the world will be in the future. He favors companies that have disruptive technologies or business models. Most of Rose’s career was spent as a senior manufacturing and business executive in the global pharmaceutical industry. He has lived and worked in places as disparate as Puerto Rico and Russia. He has had four JVs in China and worked extensively throughout Asia, including India and Australia. He is a Venture Partner in Tramway Ventures, a small seed-stage investment firm based in New Mexico and he owns and operates a biotechnology-focused business incubator, The Bioscience Center and FatPipe New Mexico, a network of collaboration/coworking spaces.
Examples of startups with which Rose is currently involved include Agilvax, a company developing a novel therapeutic for Triple Negative Breast Cancer and Colon Cancer, Biophagy, a company developing new molecules that stimulate or inhibit autophagy to treat diseases of aging, Go-Station, a company with a novel, technology-driven business model that is installing a network of electric vehicle charging stations around the United States, AdWallet, a company with a novel platform that is expected to disrupt the advertising industry by paying people instead of intermediaries to watch ads, mPower Technology, a company developing very efficient and very lightweight solar cells for applications from space to IoT and roofing.